nabu.science
MethodologyAboutContact

 

  • Snapshot
  • Key Claims
  • Strengths & Limitations
  • Commentary
  • From the Authors
  • Author Note / Field Feedback
  • Dimension breakdown
  • Impact Profile
Free · About 5 minutes
Report #NBU-0CD54780·Framework v5.0·Pipeline v0.4·Evaluated 20 May 2026·OECD: 3.2 Clinical medicine·Subfield: Experimental and Cognitive Psychology·Basis: Full text·Type: Systematic review

Applications of the experience sampling method (ESM) in paediatric healthcare: a systematic review

2023·10.1038/s41390-023-02918-2 ↗

In brief

First systematic map of ESM in paediatric chronic illness provides a useful field baseline constrained by the descriptive scope of its synthesis.

ReliabilityCaveats4 of 4 checks completeRead the entry ↓
Abstract

Abstract Background With the Experience Sampling Method (ESM) participants are asked to provide self-reports of their symptoms, feelings, thoughts and behaviours in daily life. This preregistered systematic review assessed how ESM is being used to monitor emotional well-being, somatic health, fatigue and pain in children and adolescents with a chronic somatic illness. Methods Databases were searched from inception. Studies were selected if they included children or adolescents aged 0–25 years with a chronic somatic illness and used ESM focussing on mental health or psychosocial wellbeing, biopsychosocial factors and/or somatic health. Two reviewers extracted data of the final 47 papers, describing 48 studies. Results Most studies evaluated what factors influence medical or psychological symptoms and how symptoms influence each other. Another common purpose was to study the feasibility of ESM or ESM as part of an app or intervention. Study methods were heterogeneous and most studies lack adequate reporting of ESM applications and results. Conclusions While ESM holds great potential for providing results and feedback to patients and caregivers, little use is being made of this option. Future studies should consider what they report in their studies, conduct a priori power analyses and how ESM can be embedded in clinical practice. Impact While ESM has many clinical applications, it is currently mostly used for research purposes. Current studies using ESM are heterogeneous and lack consistent, high-quality reporting. There is great potential in ESM for providing patients and parents with personalised feedback.

Strengths · Limitations

Strengths

#methodological rigour

Pre-registered design with systematic multi-database search

The review was prospectively registered in PROSPERO, searched five databases from inception with a research librarian, and reported interrater agreement at each screening stage (96.82%, 94.88%, 87.41%). Data extraction materials and quality assessments are deposited on OSF.

↳ Methods — Search strategy, Study selection, Data extraction; Data Availability section

#contribution

Transparent study-level quality assessment revealing field gaps

All 48 included studies were assessed using the van Roekel checklist, with results reported at the individual study level in Table 3. The finding that 56.25% of studies were rated poor quality and none achieved good quality is a substantive contribution to quality benchmarking in this subfield.

↳ Results — Quality of ESM data and studies; Table 3

#reporting

Clear presentation with comprehensive reference tables

Tables 1, 2, and 3 provide detailed, well-organized study-level information on purpose, sample characteristics, ESM design parameters, and quality scores. This creates a usable reference resource for researchers and clinicians planning ESM implementations in paediatric settings.

↳ Tables 1, 2, 3; Fig. 1

Limitations

#methodological rigour

Data extraction lacks full independent dual extraction

Each of the two researchers extracted data from 50% of selected articles and cross-checked the other 50%. This 50/50 split with cross-checking is a weaker approach than full independent dual extraction and reduces confidence in extraction accuracy, particularly given the complexity of the ESM-specific data points extracted.

↳ Methods — Data extraction

#methodological rigour

Missing inter-rater reliability for quality assessment

While interrater agreement is reported for all title/abstract and full-text screening stages, no inter-rater reliability statistics are provided for the quality assessment using the van Roekel checklist. Given that quality assessment results are a primary outcome of the review, this is a notable methodological gap.

↳ Methods — Quality and risk of bias; Table 3

#positioning

Non-standard upper age limit weakens paediatric framing

The inclusion of studies with participants up to age 25 extends beyond standard paediatric definitions. Several included studies feature mean participant ages above 20 years, complicating the review's framing as specifically paediatric. The methodological justification for this age boundary is limited.

↳ Methods — Eligibility criteria; Table 1 (e.g., Gevonden et al., mean age 26.5; Campbell et al., mean age 23)

Does this match your read? Add your assessment ↓

Nabu Commentary

This systematic review is the first to consolidate how ESM is applied across paediatric chronic somatic illness, and it accomplishes its descriptive aims competently. The strongest features are its transparent, pre-registered methodology and the comprehensive study-level tables that serve as a practical reference resource. The key tension in evaluating the review's craft concerns execution gaps: while the search strategy and screening process are well-documented with interrater statistics, the data extraction approach (50/50 split) and absent inter-rater reliability for quality assessment fall short of the standards reported for other procedural steps. The review's impact is inherently constrained by its descriptive scope — it maps what exists rather than providing actionable clinical guidance, but it does establish a clear baseline against which future field progress can be measured. The finding that zero studies met the threshold for 'good quality' reporting is a meaningful contribution that directly supports the review's recommendations for improved reporting standards.

Evaluate another paper

Free · About 5 minutes · Research preview

Author Note / Field Feedback

Nabu’s assessment, alongside the field’s view.

Are you an author of this paper?

Dimension breakdown

Evidence Score

Out of 5
012345
3.5±0.1

Contribution
3.3

The review fills a genuine gap as the first comprehensive overview of ESM applications in paediatric chronic somatic illness, identifying important reporting deficiencies and the absence of clinical integration. The contribution is primarily cartographic rather than empirically generative, mapping an emerging field and establishing baseline quality benchmarks (e.g., 0 of 48 studies rated good quality).

Introduction; Results, Quality of ESM data and studies; Table 3

the field of ESM in paediatrics seems in its infancy

Methodological Rigour
3.5

The review methodology is competently executed with pre-registration (PROSPERO), multi-database search by a research librarian, and documented interrater agreement at each screening stage. However, data extraction used a 50/50 split with cross-checking rather than full independent dual extraction, and inter-rater reliability for the quality assessment is not reported despite being reported for screening stages.

Methods — Search strategy, Study selection, Data extraction, Quality and risk of bias

Both researchers extracted data from 50% of selected articles and double-checked the data-extraction for the other 50%

Reporting
4.1

The paper is well-structured with clear research questions, a logical methods-to-results-to-discussion flow, and comprehensive study-level tables (Tables 1–3) and PRISMA flow diagram. Language is appropriately hedged throughout, consistently framing conclusions as descriptive and avoiding overclaiming.

Fig. 1; Tables 1, 2, 3; Abstract; Discussion and Conclusion
Positioning
3.7

The review engages appropriately with the core ESM literature and positions the paediatric chronic illness application within broader clinical trends such as value-based healthcare and shared decision-making. Limitations are honestly acknowledged, including that the quality checklist was developed for psychology research. The review does not engage deeply with the broader patient-reported outcomes literature in paediatrics or discuss potential publication bias in the included literature.

Introduction; Discussion — strengths and limitations; Discussion — clinical implications

Reliability

Caveats4 of 4 checks


Internal CoherenceClean

The paper is internally consistent across abstract, full text, tables, and PRISMA flow diagram. Numbers (47 papers, 48 studies, 1726 participants) are coherent throughout. No statistical impossibilities, methods-results mismatches, or selective reporting signs were identified.

Research ConductNoted

The study is prospectively registered in PROSPERO (CRD42022268954), declares PRISMA 2020 and AMSTAR 2 compliance, and deposits data on OSF with a specific URL and view-only token. No ethics approval is expected for a systematic review. A formal conflict of interest statement is not visible in the provided text, which is noted as a minor gap.

Flags: 2 declared / 5 total

Reference IntegrityClean

All 17 cited references resolved to real publications via PubMed, Crossref, or OpenAlex.

References not verified automatically are resolved manually within 24 hours.

Post-Publication RecordClean

No retraction or expression of concern found in Crossref (includes Retraction Watch).

Last checked: 17 Oct 2026

Sources: Crossref (incl. Retraction Watch) ✓

Impact Profile

Impact areaHealth · Generic health relevance
Type of advanceSynthesis
Route to useNamed
AdvanceExtends
CitationsFWCI 2.9
Policy · patentNot yet traced
ReachedNot reachedNot assessable or unverified
ReadinessFoundational
Foundational
Controlled
Piloted
Validated
Implementable
FoundationalImplementable

The primary claim is a descriptive mapping of how ESM is used and reported, and the paper states that clinical embedding and its effects remain to be investigated.

From the paper
“This overview can serve as inspiration for clinicians working with children with a chronic illness.”

The paper names clinicians as the actors who would use its findings to embed ESM in care for chronically ill children.

Pathway

Paediatric clinicians could embed smartphone-based ESM with personalised feedback into routine monitoring of children with chronic illness, supporting adherence and earlier intervention.

Barrier

Evidence comes from small, heterogeneous, mostly research-oriented studies with poor reporting, and no study demonstrated ESM as an independent clinical self-monitoring tool.

Evaluated 13 Nov 2026 · GBD 2023 · glm_v1_3_3 · impact_profile_v1_3_3

Report an issue →

AI-generated, human-governed. Something look off? Contact us to request a review.

Keep reading

Related evaluations

Other papers Nabu has evaluated blind, starting with the same field.

  1. A Critical Review of the Literature Regarding the Selection of Long-Term Romantic Partners

    Devenport, Davis-McCabe, Winter · 2023 · Psychology

    Evidence Score
    3.2±0.2
    Reliability
    No concerns
  2. Diverse Gender and Sexual Identity in Romantic Partner Selection Experiences: An Exploration of Similarities, Differences, and Potential Explanations

    Devenport, Davis-McCabe, Mullan, et al. · 2025 · Psychology

    Primary claim

    Factor analysis replicated established trait preference dimensions in this large, heterogeneous Australian sample, with dimensions remaining stable in majority and minority subsamples.

    Tentative
    Evidence Score
    3.2±0.2
    Reliability
    Caveats
  3. Creative or Uncreative Partner: Comparing Humans and AI in Collaborative Creative Tasks

    Clin KY Lai, Simone A Luchini, Nina Lauharatanahirun, et al. · 2026 · Psychology and cognitive sciences

    Primary claim

    Our findings reveal that the apparent "AI advantage" in creative collaboration is illusory, driven primarily by increased AI verbosity rather than enhanced creativity.

    Tentative
    Evidence Score
    2.8±0.1
    Reliability
    Caveats

How the rubric works →